SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pete who wrote (478)4/19/1999 9:06:00 PM
From: Larry G.  Read Replies (2) of 792
 
Hi Pete,

Sorry no options at the end of April.

Dany Hadary has been talking to a lot of analysts. MBI for a long time have been ignoring the analysts and concentrating on the science. MBI have been talking to a number of analysts but have been concentrating on 4 main analysts, the big banks and Yorkton Securities (Yorkton does a lot of health sciences). Their reports are going to come out soon. I hear that Yorkton's report is out. I hear that Yorkton think that MBI is undervalued and they think that the market has not recognized the progress that MBI has made. Yorkton thinks the share price should be $7.30 now and that it share price should be $22.00 by year 2002.

The results of Phase one should be released next week. MBI are doing a lot of preparations for phase 2 so they are very confident that phase one will be successful.

I do not understand why more people are not buying. I mortgaged my house to buy shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News